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OBJECTIVES The purpose of this study was to determine if atrial pacing is effective in reducing
postoperative atrial fibrillation (AF).
BACKGROUND Atrial fibrillation after coronary artery bypass grafting (CABG) is a common problem for
which medical management has been disappointing. Atrial-based pacing has become an
attractive nonpharmacologic therapy for the prevention of AF.
METHODS Sixty-one post-CABG patients (mean age 5 65 years) were randomized to one of three
groups: no atrial pacing (NAP), right atrial pacing (RAP) or biatrial pacing (BAP). Each
patient had one set of atrial wires attached to both the right and left atria, respectively, at the
conclusion of surgery. Patients in the RAP and BAP groups were continuously paced at a rate
of 100 pulses per minute for 96 h or until the onset of sustained AF (.10 min). All patients
were monitored with Holter monitors or full disclosure telemetry to identify the onset of AF.
The primary end point of the study was the first onset of sustained AF.
RESULTS There was no significant difference in the proportion of patients developing AF in the three
groups (NAP 5 33%; RAP 5 29%; BAP 5 37%; p . 0.7). However, for the subset of
patients on beta-adrenergic blocking agents after CABG, there was a trend toward less AF
in the paced groups. There were no serious complications related to pacing, although in three
patients the pacemaker appeared to induce AF by pacing during atrial repolarization.
CONCLUSIONS Continuous right or biatrial pacing in the postoperative setting is safe and well tolerated. We
did not find that post-CABG pacing prevented AF in this pilot study; however, the role of
combined pacing and beta-blockade merits further study. (J Am Coll Cardiol 1999;33:
1981–8) © 1999 by the American College of Cardiology
Atrial fibrillation (AF) after coronary artery bypass graft
(CABG) surgery is a common and vexing problem. Treat-
ment with electrical cardioversion, antiarrhythmic drugs and
anticoagulation adds significant morbidity and cost (1,2).
Prophylactic pharmacologic treatment has been disappoint-
ing. Although a recent trial found a significant reduction in
postoperative AF with amiodarone treatment (3), the inci-
dence of AF in the treatment group was still 25%, and
concerns about potential morbidity exist.
Nonpharmacologic strategies for prevention of atrial
fibrillation have become more attractive because they avoid
the toxicity of antiarrhythmic drugs. There is a growing
body of evidence that atrial-based pacing is effective in
reducing recurrences of paroxysmal AF. Retrospective and
prospective studies have suggested that patients who receive
atrial or dual chamber pacemakers experience fewer episodes
of AF than those receiving traditional ventricular demand
pacemakers (4–12). New evidence has recently emerged
suggesting that biatrial pacing can be more effective than
standard right atrial pacing in decreasing recurrences of
paroxysmal AF (13). Although investigation of these strat-
egies is ongoing, they are currently limited to patients
undergoing pacemaker implantation for other indications,
usually sick sinus syndrome.
Patients undergoing CABG surgery may provide a model
to examine the impact of prophylactic atrial pacing, since
they have temporary atrial and ventricular pacing wires
implanted at the time of surgery, and a high incidence of
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AF. Such a technique would also be extremely useful
clinically in reducing the cost and morbidity associated with
postoperative AF. In this pilot study, we sought to evaluate
the safety and tolerance of continuous atrial pacing after
CABG. We hypothesized that a strategy of temporary right
atrial or biatrial pacing after CABG would reduce the
incidence of postoperative AF compared with that in
nonpaced patients.
METHODS
Patient population. Patients 18 years of age and older who
were scheduled for elective CABG at the University of
Massachusetts Medical Center (UMMC) were approached
for enrollment in the study. All patients had to be in sinus
rhythm before surgery and on no antiarrhythmic medica-
tions. Recruitment occurred between April 1, 1995 and
December 31, 1995. Patients were randomly assigned in a
single blinded fashion to one of three groups: no atrial
pacing (NAP), right atrial pacing (RAP) or biatrial pacing
(BAP). Patients were randomized before surgery and fol-
lowed for up to 96 h postoperatively.
Patients were excluded from the study if they had a
known history of AF or atrial flutter requiring antiarrhyth-
mic medications, had renal or hepatic dysfunction (serum
creatinine .3, liver enzyme tests .33 normal) or were
unable to give informed consent. In addition, patients in
whom epicardial pacing wires could not be placed during
surgery, or patients who developed ventricular arrhythmias
requiring therapy with oral or intravenous antiarrhythmic
agents other than intravenous lidocaine after surgery were
excluded from the study group. Patients who required
temporary pacing immediately after surgery due to hemo-
dynamic compromise remained in the study.
Baseline characteristics and arrhythmia history were as-
certained from direct patient interviews and review of the
medical record. The ejection fraction was calculated by left
ventriculography in the right anterior oblique projection
during preoperative cardiac catheterization. P-wave dura-
tion was measured from lead II of the preoperative electro-
cardiogram.
The protocol was approved by the Human Subjects
Committee of UMMC, and all patients signed an informed
consent before participating.
Study protocol. All patients had one set of ventricular and
two sets of atrial bipolar pacing wires implanted at the
conclusion of surgery (Medtronic model #6500, Minneap-
olis, Minnesota). One pair of atrial wires was implanted in
the standard location 1 cm apart along the high lateral right
atrium near the sinus node. A second pair was attached to
the posterior surface of the left atrium between the right
superior and inferior pulmonic veins. These two pairs of
wires were connected by a Y connector to the atrial input of
the temporary pacemaker for biatrial pacing. The ventricular
wires were attached to the right ventricular apex in the
standard fashion.
Patients in the NAP group were paced in the ventricular
single-chamber pacing mode at a backup rate of 50 pulses
per minute (ppm) while in the surgical intensive care unit,
and had no pacing while in the hospital ward as is the
standard practice at UMMC. Patients in the RAP and BAP
groups were paced with a temporary external dual chamber
pacemaker (Medtronic model #5346) in the AV universal
(DDD) mode at a lower rate limit of 100 ppm with an
atrioventricular (AV) delay of 220 ms to establish continu-
ous atrial pacing at rest. Pacemaker settings including an
upper-rate limit of 140 ppm, a postventricular atrial refrac-
tory period of 175 ms, atrial sensitivity of 0.5 mV, ventric-
ular sensitivity of 2 mV and maximum atrial and ventricular
pacing output of 20 mA. Pacing was continued for 96 h or
until the first sustained episode of AF (.10 min). Patients
in the NAP group requiring pacing due to hemodynamic
compromise were paced in the atrial single-chamber pacing
or AV universal mode at the discretion of the attending
physician, and were subsequently returned to their assigned
mode when their condition allowed this to occur.
Physicians were instructed to continue beta-adrenergic
blocking agents postoperatively in all patients receiving
preoperative beta-blocker therapy. Preoperative beta-
blockers were continued through the morning of surgery,
and metoprolol 25 mg orally twice daily was instituted
postoperatively as soon as all intravenous inotropes were
discontinued. The dose was titrated upward at the discretion
of the attending surgeon. Patients not on beta-blockers
preoperatively were not started on beta-blockers in the
postoperative period. Patients prescribed verapamil, digoxin
or diltiazem preoperatively received alternative medications
postoperatively with no effect on AV nodal conduction.
Patients were continuously monitored during the study
period with a full disclosure telemetry system (HP CareVue,
Hewlett-Packard Co., Burlington, Massachusetts) or con-
tinuous Holter monitoring. Both surface lead II and elec-
trograms from the right atrial electrode pair were recorded
on the Holter monitors (Fig. 1). Bipolar pacing and sensing
thresholds for both atrial leads were checked after arrival at
the intensive care unit and daily thereafter to ensure atrial
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capture. The underlying heart rhythm and rate were docu-
mented daily. When considered stable, patients were trans-
ferred out of the intensive care unit to monitored beds in the
general hospital ward where pacing was continued for the
remainder of the study period.
The primary end point of the study was the initial
occurrence of AF or atrial flutter with a ventricular rate
greater than 100 beats/min for 10 consecutive minutes, or
completion of the 96-h monitoring period. An investigator
reviewed the hospital chart and full disclosure telemetry at
least once daily to monitor the cardiac rhythm and establish
the time of onset of AF. The exact time of onset was
confirmed using the Holter monitor.
Previous studies have suggested that the use of beta-
blockers is associated with a reduced incidence of postop-
erative AF. Therefore, it was predetermined that the effects
of beta-blockers on the incidence of AF would be analyzed
for each group. Patients were defined as being on beta-
blockers only if they were taking the medication for at least
24 h before the onset of AF. All cardiac medications
administered over the previous 24 h were documented daily
by an investigator throughout the study period.
Data analysis. All values are expressed as mean 6 standard
deviation. Baseline characteristics of the study groups were
compared using Student t test or analysis of variance for
continuous variables, and the chi-square test for discrete
variables. The principal study outcomes were examined
using a logistic multivariate regression analysis that con-
trolled for baseline variables that were possible confounders
(p , 0.1). These controlling variables included a history of
prior myocardial infarction (MI) and intraoperative cross-
clamp time. Odds ratios (ORs) and 95% confidence inter-
vals (CIs) were calculated in the standard manner. Predic-
tors of AF were initially determined by univariate analysis
with chi-square or Student t test, and then entered into a
multivariate regression model to ascertain independent pre-
dictors.
We used Holter monitoring to detect all episodes of AF,
both clinically apparent as well as that detected by electro-
cardiography alone, and we anticipated a 50% incidence of
AF. Enrolling 20 patients per group allowed us 80% power
to detect a reduction of AF to 10% in either pacing arm
compared with no pacing.
Statistics were calculated using SAS version 6.12 (Cary,
North Carolina). All patients were initially analyzed in their
original randomized groups, on an intention-to-treat basis,
and then based on treatment received.
RESULTS
A total of 65 patients were enrolled in the study. Four
patients were dropped from the study after randomization
based on the predefined criteria: one patient developed AF
intraoperatively and was started on procainamide, one
patient did not have a second set of atrial wires implanted
for technical reasons, one patient had a postoperative course
complicated by multiorgan system disease and was elimi-
nated at the request of the attending physician and one
patient asked to be dropped from the study on the first
postoperative day because of hiccups that were attributed to
pacing. No patients were withdrawn because of ventricular
arrhythmias. The final study population consisted of 61
patients.
Of the 61 patients enrolled, 45 (74%) were men with an
average age of 65 years. Twenty-one patients were randomly
Figure 1. Sample Holter monitor tracings recorded from one patient during the onset and termination of atrial fibrillation (AF). In each
figure the top tracing is a bipolar recording from the right atrial epicardial wires, and the bottom tracing is a recording from surface lead
I. In A, the second atrial premature beat (arrow) initiates a rapid atrial rhythm of varying morphology which can easily be identified by
the atrial electrograms. On the surface electrocardiogram this rhythm appeared to be AF. B demonstrates the spontaneous conversion of
AF to sinus rhythm in the same patient.
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assigned to the NAP and RAP groups each, and 19 to the
BAP group. Baseline characteristics of the groups are
presented in Table 1. Patients in the RAP group included a
significantly greater proportion of patients with prior MI;
patients in the BAP group had a significantly shorter
operative cross-clamp time. There was no significant differ-
ence between preoperative and postoperative beta-blocker
use.
Right atrial and biatrial pacing were well tolerated. Mean
pacing threshold for the RAP group was 2.0 mV. In the
BAP group, mean left atrial pacing threshold was signifi-
cantly greater than mean right atrial pacing threshold (3.2
vs. 1.6 mA; p , 0.001). Some patients in the BAP group
initially complained of discomfort from diaphragmatic pac-
ing; however, this was easily corrected by decreasing the
pacemaker output.
No complications were attributed to the implantation of
the second set of atrial wires in the left atrium. One patient
died in the intensive care unit on the 3rd postoperative day
due to a respiratory arrest. No other patients died during the
study period.
Three patients crossed over to other groups after random-
ization. One patient in the BAP group returned to the
operating room on the first postoperative day because of
mediastinal bleeding, and did not have the atrial wires
reimplanted. This patient remained unpaced for the re-
mainder of the study period. A second patient who was in
the RAP group had their pacemaker turned off on the
second postoperative day to relieve uncomfortable diaphrag-
matic pacing. The third patient, who was in the NAP
group, was paced from the right atrium for the entire 96-h
study period due to persistent bradycardia. In addition, four
patients in the NAP group required temporary pacing in the
postoperative period due to bradycardia: three until postop-
erative day 1, and one until postoperative day 2.
Pacing efficacy. There was no significant difference in the
proportion of patients developing AF in the three groups
(NAP 5 33%, RAP 5 29%, BAP 5 37%; SAP vs. NAP
adjusted OR 5 1.01, 95% CI 0.25, 4.07; BAP vs. NAP
adjusted OR 5 1.31, 95% CI 0.32, 5.38; p . 0.7) (Fig. 2).
The mean time to onset of AF was significantly shorter in
the BAP group than the other two groups (NAP 5 59 6
19 h, RAP 5 54 6 29 h, BAP 5 27 6 8 h; p , 0.02).
There was no significant difference in the total time spent in
the intensive care unit (NAP 5 49 6 54 h, RAP 5 64 6
137 h, BAP 5 47 6 25 h; p . 0.6), or in the total
hospitalization time (NAP 5 158 6 99 h, RAP 5 164 6
195 h, BAP 5 163 6 113 h; p . 0.5) among the groups.
Occurrences of atrial fibrillation were equally distributed
throughout the 96-h monitoring period (Fig. 3). No pa-
tients in the study developed atrial flutter.
Among patients receiving beta-blocker therapy there was
a trend toward fewer episodes of AF in the BAP group (Fig.
2). No patients on beta-blocker therapy who actually received
BAP developed AF. One patient randomized to the BAP
group did develop AF, but this patient was never paced because
the wires had been removed on postoperative day 1.
On-treatment analysis. When patients were analyzed ac-
cording to the pacing treatment they actually received, there
was again no statistically significant difference in the pro-
portion of patients developing AF among the three groups
(NAP 5 36%, RAP 5 29%, BAP 5 33%; SAP vs. NAP
adjusted OR 5 1.13, 95% CI 0.28, 4.58; BAP vs. NAP
adjusted OR 5 1.72, 95% CI 0.43, 6.80; p . 0.4).
However, for patients receiving beta-blocker therapy (n 5
39), there was a statistically significant reduction in the
proportion of patients developing atrial fibrillation in the
paced groups (NAP 5 38%, RAP 5 15%, BAP 5 0%; p ,
0.05). This reduction remained of borderline statistical
significance when a multivariate regression analysis was
Table 1. Sample Characteristics
Characteristic
NAP
(n 5 21)
RAP
(n 5 21)
BAP
(n 5 19)
p
Value
Age (mean 6 SD, y) 65 6 13 65 6 10 65 6 10 NS
Hypertension* (%) 67 62 74 NS
History of alcohol use† (%) 19 33 26 NS
Chronic obstructive pulmonary disease (%) 5 0 5 NS
Prior myocardial infarction* (%) 33 67 26 0.02
Diabetes mellitus (%) 38 29 21 NS
History of atrial fibrillation or flutter (%) 0 5 11 NS
P-wave duration (mean 6 SD, ms) 108 6 17 104 6 20 107 6 16 NS
Preoperative beta-blocker use (%) 71 81 68 NS
Postoperative beta-blocker use (%) 71 76 58 NS
Ejection fraction (mean 6 SD) 63 6 11 54 6 13 60 6 13 NS
Operative data
Cross clamp time (mean 6 SD, min) 79 6 30 78 6 25 59 6 18 0.02
Bypass time (mean 6 SD, min) 128 6 45 127 6 36 107 6 25 NS
*Determined by patient interview and review of medical record. †More than 1 oz. of alcohol per day.
BAP 5 biatrial pacing; NAP 5 no atrial pacing; RAP 5 right atrial pacing.
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performed which controlled for cross-clamp time and his-
tory of MI (p 5 0.06).
Predictors of AF. Overall, 20 (33%) of the patients devel-
oped postoperative AF, which agrees with previous pub-
lished reports (1). In a univariate analysis, patients who
developed AF were significantly older, had a longer p-wave
duration on baseline electrocardiogram, were more likely to
have a history of hypertension and were less likely to receive
beta-blockers than those who remained in sinus rhythm.
Figure 2. The proportion of patients developing atrial fibrillation (AF) among all the patients, and among the subset of patients on
beta-blockers using an intention-to-treat analysis. There was a trend toward a reduction in the incidence of AF among the patients on
beta-blockers receiving biatrial pacing (BAP). The one patient who developed AF in the BAP group (asterisk) was never actually paced
because of postoperative complications. The numbers above the bars indicate the absolute number of patients in each category. Hatched
bars 5 no atrial pacing; black bars 5 right atrial pacing; white bars 5 BAP.
Figure 3. Cumulative incidence of atrial fibrillation (AF) throughout the study. Each bar represents the cumulative incidence of AF
through 24, 48, 72 and 96 h, respectively. Although the peak incidence of AF was during the 24 to 48 h period, patients continued to
develop AF until the study was completed after 96 h.
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Total hospital time was significantly longer among patients
developing atrial fibrillation. This was mainly due to extra
time spent on the hospital ward (see Table 2). After surgery,
there was no difference in mean heart rate between patients
who went on to develop AF compared with those who did
not (AF vs. no AF; 81 6 14 vs. 85 6 15 beats/min; p . 0.3).
A multivariate regression analysis was performed which
included history of prior MI, cross-clamp time, age, p-wave
duration, history of hypertension and postoperative beta-
blocker use as potential predictors of AF. The only factors
significantly associated with development of postoperative
AF were patient age greater than 65 years (adjusted OR 5
6.01, 95% CI 1.03, 35.08, p , 0.05) and beta-blocker use
(adjusted OR 5 0.07, 95% CI 0.01, 0.44, p , 0.01).
Initiation of AF. We examined the onset of AF in all
patients with good quality recordings to try and gain some
insight into the mechanism of AF initiation. Holter mon-
itor or telemetry data were available to examine the onset of
AF in 17 of the 20 patients. In 11 patients, AF began after
an APB (Fig. 1A). In three patients, AF began after a wide
complex ventricular beat which may have been either a
ventricular premature beat or an atrial premature beat
(APB) with aberrant conduction. In three patients, one in
the RAP group and two in the BAP group, the pacemaker
may have inadvertently initiated AF. There were no cases
where AF developed after a long pause.
The three cases where the pacemaker may have initiated
AF are shown in Figure 4. In one case, transient loss of
atrial sensing caused the atrial pacemaker spike to fall
progressively later after atrial depolarization until AF was
initiated (Fig. 4A). In two cases, failure of the pacemaker to
sense an APB led to an atrial pacemaker spike during atrial
repolarization, which appeared to initiate AF (Fig. 4B and
C). These spikes occurred during the initial part of the QRS
complex and would have been difficult to delineate without
the Holter recording of the atrial electrograms.
DISCUSSION
Most evidence suggests that AF is a reentrant rhythm
consisting of multiple wandering wavelets of electrical
activity (14,15). It is often initiated by an APB encountering
areas of slow conduction and unidirectional block (16).
There are many reasons why one might expect atrial pacing
to be effective in preventing AF. Increasing atrial rate
suppresses the APBs which may initiate AF. A prospective
randomized trial found that AF recurrences are reduced in
patients receiving right atrial pacing compared with ventric-
ular pacing (12). Biatrial pacing is a new technique that may
have improved efficacy in preventing AF by shortening
intra-atrial conduction delays, decreasing dispersion of re-
fractoriness and increasing the conduction velocity and
refractory period of APBs (17). Papageorgiou et al. (18)
found that the posterior triangle of Koch is a critical area of
slow conduction, and that coronary sinus (i.e., left atrial)
pacing prevented the induction of AF by high right atrial
APBs. Saksena and colleagues (13), in a small randomized
crossover trial, found that biatrial pacing was useful clini-
cally in reducing the time to first recurrence of AF in
patients receiving permanent pacemakers. Slow conduction
and increased dispersion of refractoriness have also been
implicated in the pathogenesis of postoperative AF (19).
This trial is the first to examine whether right atrial or
biatrial pacing strategies are safe and effective for preventing
AF in the postoperative setting.
In our study, temporary right or biatrial pacing after
CABG surgery had no effect in reducing occurrences of AF.
Table 2. Characteristics of Patients Developing Atrial Fibrillation
Characteristic AF (n 5 20) No AF (n 5 41) p Value
Age (mean 6 SD, yr) 72 6 7 62 6 11 ,0.001
History of hypertension* (%) 85 59 ,0.05
History of alcohol use† (%) 30 24 NS
Chronic obstructive pulmonary disease (%) 5 2 NS
Prior myocardial infarction* (%) 30 49 NS
Diabetes mellitus (%) 35 27 NS
History of atrial fibrillation or flutter (%) 10 2 NS
P-wave duration (mean 6 SD, ms) 114 6 12 102 6 19 ,0.05
Postoperative beta-blocker use (%) 48 79 ,0.05
Ejection fraction (mean 6 SD) 58 6 13 58 6 13 NS
Operative data
Cross-clamp time (mean 6 SD, min) 75 6 22 71 6 28 NS
Bypass time (mean 6 SD min) 123 6 31 120 6 40 NS
Hospitalization time
SICU (mean 6 SD, min) 77 6 139 42 6 41 NS
Ward (mean 6 SD, min) 151 6 118 88 6 37 ,0.005
Total hospitalization (mean 6 SD, min) 228 6 211 129 6 53 ,0.01
*Ascertained by patient interview and review of medical record. †More than 1 oz. of alcohol per day.
AF 5 atrial fibrillation; SICU 5 surgical intensive care unit.
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However, there was evidence that those patients treated
with both beta-blockade and pacing had a trend toward
fewer occurrences of AF. Pacing was well tolerated in all
patients and did not increase hospitalization time. There
were no complications related to the placement of left atrial
pacing wires at the conclusion of surgery.
There are several possible reasons why our results differed
from those of previous studies. The initiation of AF in the
postoperative setting is likely different than in patients with
sick sinus syndrome or pacing-induced AF. Although Cox
and colleagues (19) have demonstrated that the develop-
ment of postoperative AF is related to slow conduction and
increased dispersion of refractoriness in the atria, postoper-
ative patients also have a high catecholamine state, postop-
erative pericarditis, frequent fluid and electrolyte shifts and
respiratory compromise. These factors may alter the elec-
trophysiologic substrate for AF, thereby making pacing less
effective in its prevention. It is possible that therapies
helpful in the prevention of outpatient AF may be different
than those required in the postoperative setting.
We detected some cases of AF that appeared to have been
triggered by the pacemaker after failure to sense an atrial
depolarization. In patients with frequent APBs, inappropri-
ate pacing during atrial repolarization could paradoxically
increase the incidence of AF in some patients, eliminating
the beneficial effects of pacing. This may explain our finding
that patients in the BAP group who developed AF had a
shorter time to onset of AF than the other groups. Perma-
nent atrial pacing systems have better sensing characteristics
than the temporary pacemakers used in the intensive care
unit. Nevertheless, the possibility of pacemaker-induced AF
should be recognized, and may need to be addressed in
future trials of prophylactic pacemaker therapy.
Role of beta-blockers. The beneficial effect of beta-
blockers in preventing postoperative AF has been well
described (20,21). We also found a significant reduction in
postoperative AF among patients taking beta-blockers.
Although the population of patients on beta-blockers in our
study was not large enough to show a statistically significant
benefit from pacing, the fact that there were no occurrences
of AF in patients on beta-blockers who received BAP is
encouraging. Excess catecholamines in the postoperative
patients may be one reason why pacing was not effective in
suppressing AF. Perhaps by blocking catecholamines and
reducing the resting heart rate and number of APBs,
beta-blockers may enhance the ability of pacemakers to
prevent the initiation of AF and minimize the likelihood of
pacemaker-induced AF.
Risk factors for AF. Our results agree with larger retro-
spective studies (1,2) which found age to be an independent
risk factor for postoperative AF. We did not find cross-
clamp time or p-wave duration in lead II to be an indepen-
dent predictor of AF. The patients in our study who
developed AF spent nearly 100 h more in the hospital than
those who did not. Most of this time was spent in the
hospital wards, presumably waiting for therapeutic antico-
agulation. This highlights the need for continued investi-
gation into methods of AF prevention and early hospital
discharge in these patients. Patients over age 65 years are a
particularly high risk group that may benefit from targeted
therapy.
Limitations. In this pilot study, the patient population was
small. Therefore, our findings of no reduction in AF in the
entire patient population, and a trend toward a reduction of
AF in paced patients on beta-blockers, are less definitive
than they would have been had a larger group of patients
been studied. In particular, we cannot exclude a smaller
benefit to right atrial or biatrial pacing compared with no
pacing in the entire patient population than we were able to
detect. These data suggest that a study in a larger group of
patients, all of whom are on beta-blockers, should be
performed to confirm these preliminary observations.
We did not include an enrollment registry in our study,
therefore we cannot comment on differences between the
population we studied and those patients who declined to
enroll. Since consecutive patients were approached for
participation, and the baseline characteristics of our popu-
lation are similar to that reported by large observational
Figure 4. Holter monitor tracings recorded from three patients in
whom atrial fibrillation (AF) appeared to be initiated by the
pacemaker. The top tracing is a bipolar recording from the right
atrial epicardial wires showing the atrial pacing spikes, and the
bottom tracing is a recording from surface lead I. In A, a failure
of pacemaker sensing caused the atrial pacing spike to fall
progressively later after atrial depolarization until AF was initiated
when a pacing spike (open arrow) occurred during a critical period
of atrial repolarization. In B and C an atrial premature beat (filled
arrow) occurs which is not sensed appropriately by the pacemaker.
The next pacing spike (open arrow) occurs during atrial repolar-
ization and the rhythm converts to AF. A ventricular spike also
occurs due to safety pacing.
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studies (2), we think that the study group was a represen-
tative sample of patients undergoing CABG.
The temporary pacemakers in the paced groups were set
to a rate of 100 beats/min to try to ensure continuous pacing
without causing hemodynamic compromise. Some patients
with an intrinsic heart rate greater that 100 beats/min may
not have been continuously paced. Our records indicate that
continuous pacing occurred .90% of the time in the paced
patients, however, making this an unlikely confounder.
There were no patients randomized to pacing who devel-
oped atrial fibrillation while the pacemaker was inhibited
due to sinus tachycardia.
Cox and colleagues have demonstrated that the duration
of cross-clamp time is a risk factor for the development of
postoperative AF (22). This raises the question of whether
the shorter cross-clamp time in the BAP group could be
responsible for a reduction of AF in that group. Cross-
clamp time is only a significant risk factor for AF in patients
undergoing aortic valve replacement, a group excluded from
our study. Furthermore, the trend toward less AF in
patients with BAP on beta-blockers persisted even after
correcting for this confounder, making it an unlikely expla-
nation for our results.
Conclusions. Continuous right or biatrial pacing in the
postoperative setting is safe and well tolerated. In this pilot
study, we find that temporary right or biatrial pacing did not
prevent postoperative AF. Temporary pacing may paradox-
ically induce AF in some patients if inappropriate sensing
leads to pacing during atrial repolarization. The role of
combined pacing and beta-blockade shows some promise
for reducing the incidence of postoperative AF and deserves
further study.
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